[{"NetIncomeLoss_1_Q1_USD":-6815000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":1559868.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-4.37,"CommitmentsAndContingencies_0_Q1_USD":null,"InterestIncomeOther_1_Q1_USD":42000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":2558000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-54000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-64773000.0,"Depreciation_1_Q1_USD":79000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":186148000.0,"AssetsCurrent_0_Q1_USD":310545000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":42533826.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":25000.0,"LeaseAndRentalExpense_1_Q1_USD":22000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-54000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":1497000.0,"CommonStockSharesIssued_0_Q1_shares":49254311.0,"ConversionOfStockSharesIssued1_1_Q1_shares":1.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":1015000.0,"TemporaryEquitySharesAuthorized_0_Q1_shares":200000000.0,"CommonStockValue_0_Q1_USD":5000.0,"OtherNonoperatingIncome_1_Q1_USD":42000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":160214000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-503000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":186950000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":296000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":124000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":35000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-6869000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-63000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q1_USD":0.0001,"OtherAssetsNoncurrent_0_Q1_USD":201000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":221036000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Assets_0_Q1_USD":311245000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-54000.0,"ShareBasedCompensation_1_Q1_USD":296000.0,"MarketableSecurities_0_Q1_USD":88835000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":116120000.0,"CommonStockSharesOutstanding_0_Q1_shares":49254311.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":64711000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":509000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6057000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":54700000.0,"LiabilitiesCurrent_0_Q1_USD":4851000.0,"AccountsPayableCurrent_0_Q1_USD":1621000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":674000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":23000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":260000.0,"AdditionalPaidInCapital_0_Q1_USD":347405000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":499000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-40962000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":62000.0,"StockholdersEquity_0_Q1_USD":306394000.0,"ProfitLoss_1_Q1_USD":-6815000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":66000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-6857000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":5360000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":187051000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":311245000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":672000.0,"PreferredStockSharesAuthorized_0_Q1_shares":200000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":296000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1008000.0,"OperatingExpenses_1_Q1_USD":6857000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-4.37,"PreferredStockValue_0_Q1_USD":null,"ConversionOfStockAmountConverted1_1_Q1_USD":160214000.0,"Ticker":"EWTX","CIK":"1710072","name":"EDGEWISE THERAPEUTICS, INC.","OfficialName":"Edgewise Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"388173759.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210513"}]